A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

NCT ID: NCT03975647

Last Updated: 2025-12-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

466 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-02

Study Completion Date

2029-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) or cannot be removed completely with surgery.

Patients in this study will be randomly assigned to get either tucatinib or placebo (a pill with no medicine). This is a blinded study, so neither patients nor their doctors will know whether a patient gets tucatinib or placebo. All patients in the study will get T-DM1, a drug that is often used to treat this cancer.

Each treatment cycle lasts 21 days. Patients will swallow tucatinib pills or placebo pills two times every day. Patients will get T-DM1 injections from the study site staff on the first day of every cycle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in participants with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Participants will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1.

While on study treatment, participants will be assessed for progression every 6 weeks for the first 24 weeks, and every 9 weeks thereafter, irrespective of dose holds or interruptions. Study treatment will continue until unacceptable toxicity, disease progression, withdrawal of consent, or study closure. After completion of study treatment and after occurrence of disease progression, participants in both arms of the study will continue to be followed for survival until study closure or withdrawal of consent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HER2-positive Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tucatinib + T-DM1

Tucatinib + T-DM1

Group Type EXPERIMENTAL

tucatinib

Intervention Type DRUG

300mg given twice per day by mouth (orally)

T-DM1

Intervention Type DRUG

3.6 mg/kg given into the vein (IV; intravenously) every 21 days

Placebo + T-DM1

Placebo + T-DM1

Group Type ACTIVE_COMPARATOR

placebo

Intervention Type DRUG

Given twice per day orally

T-DM1

Intervention Type DRUG

3.6 mg/kg given into the vein (IV; intravenously) every 21 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tucatinib

300mg given twice per day by mouth (orally)

Intervention Type DRUG

placebo

Given twice per day orally

Intervention Type DRUG

T-DM1

3.6 mg/kg given into the vein (IV; intravenously) every 21 days

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ONT-380 Kadcyla

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically confirmed HER2+ breast carcinoma as determined by a sponsor-designated central laboratory
* History of prior treatment with a taxane and trastuzumab in any setting, separately or in combination
* Have progression of unresectable locally advanced/metastatic breast cancer after last systemic therapy, or be intolerant of last systemic therapy
* Measurable or non-measurable disease assessable by RECIST v1.1
* ECOG performance status score of 0 or 1
* CNS Inclusion - Based on screening contrast brain magnetic resonance imaging (MRI), participants must have at least one of the following:

(a) No evidence of brain metastases

(b) Untreated brain metastases not needing immediate local therapy

(c) Previously treated brain metastases
1. Brain metastases previously treated with local therapy may either be stable since treatment or may have progressed since prior local CNS therapy, provided that there is no clinical indication for immediate re-treatment with local therapy
2. Participants treated with CNS local therapy for newly identified lesions or previously treated and progressing lesions may be eligible to enroll if all of the following criteria are met:

(i) Time since SRS is at least 7 days prior to first dose of study treatment, time since WBRT is at least 14 days prior to first dose, or time since surgical resection is at least 28 days.

(ii) Other sites of evaluable disease are present
3. Relevant records of any CNS treatment must be available to allow for classification of target and non-target lesions

Exclusion Criteria

* Prior treatment with tucatinib, afatinib, trastuzumab deruxtecan (DS-8201a), or any other investigational anti-HER2, anti-EGFR, or HER2 TKI agent. Prior treatment with lapatinib or neratinib within 12 months of starting study treatment (except in cases where they were given for ≤21 days and was discontinued for reasons other than disease progression or severe toxicity). Prior treatment with pyrotinib for recurrent of mBC (except in cases where pyrotinib was given for ≤21 days and was discontinued for reasons other than disease progression or severe toxicity).
* CNS Exclusion - Based on screening contrast brain magnetic resonance imaging (MRI), participants must not have any of the following:

1. Any untreated brain lesions \>2 cm in size
2. Ongoing use of corticosteroids for control of symptoms of brain metastases at a total daily dose of \>2 mg of dexamethasone (or equivalent).
3. Any brain lesion thought to require immediate local therapy
4. Known or concurrent leptomeningeal disease as documented by the investigator
5. Poorly controlled generalized or complex partial seizures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seagen, a wholly owned subsidiary of Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Alabama Health Children's and Women's Hospital

Mobile, Alabama, United States

Site Status

University of South Alabama Mitchell Cancer Institute

Mobile, Alabama, United States

Site Status

University of South Alabama Health University Hospital

Mobile, Alabama, United States

Site Status

Banner Gateway Medical Center

Gilbert, Arizona, United States

Site Status

Banner MD Anderson Cancer Center

Gilbert, Arizona, United States

Site Status

Western Regional Medical Center, LLC

Goodyear, Arizona, United States

Site Status

Arizona Oncology Associates, PC - HOPE.

Tucson, Arizona, United States

Site Status

Arizona Oncology Associates, PC - HOPE

Tucson, Arizona, United States

Site Status

Arizona Oncology Associates, PC - HOPE

Tucson, Arizona, United States

Site Status

UCLA Hematology/Oncology - Alhambra

Alhambra, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Antioch, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Antioch, California, United States

Site Status

UCLA Hematology/Oncology- Beverly Hills

Beverly Hills, California, United States

Site Status

UC Irvine Health Cancer Center - Newport

Costa Mesa, California, United States

Site Status

City of Hope Investigational Drug Services (IDS)

Duarte, California, United States

Site Status

City of Hope(City of Hope National Medical Center,City of Hope Medical Center)

Duarte, California, United States

Site Status

Kaiser Permanente Medical Center (Radiology)

Dublin, California, United States

Site Status

UCLA Hematology/Oncology - Encino

Encino, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Fairfield, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Gilroy, California, United States

Site Status

UCLA Hematology/Oncology- Irvine

Irvine, California, United States

Site Status

Drug Management Only: UCLA West Medical Pharmacy, Attn: Steven L Wong, Pharm.D.

Los Angeles, California, United States

Site Status

Regulatory Management only: TRIO-US Central Administration

Los Angeles, California, United States

Site Status

Ronald Reagan UCLA Medical Center

Los Angeles, California, United States

Site Status

UCLA Hematology/Oncology

Los Angeles, California, United States

Site Status

UCLA West Medical Pharmacy

Los Angeles, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Martinez, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Milpitas, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Modesto, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Mountain View, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Napa, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

Oakland, California, United States

Site Status

Kaiser Permanente Medical Center (Radiology)

Oakland, California, United States

Site Status

Chao Family Comprehensive Cancer Center University of California Irvine

Orange, California, United States

Site Status

UC Irvine Medical Center Attn: Trisha Maris

Orange, California, United States

Site Status

UCI Medical Center - Chao Family Comprehensive Cancer Center

Orange, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Pleasanton, California, United States

Site Status

UCLA Hematology/Oncology - Porter Ranch

Porter Ranch, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

Redwood City, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

Roseville, California, United States

Site Status

Kaiser Permanente Sacramento J Street Medical Center (clinic+DSL+Lab Drawing Station)

Sacramento, California, United States

Site Status

University of California Davis Medical Center

Sacramento, California, United States

Site Status

University of California Davis

Sacramento, California, United States

Site Status

Kaiser Permanente Medical Center (Radiology)

Sacramento, California, United States

Site Status

Zuckerberg San Francisco General Hospital

San Francisco, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

San Francisco, California, United States

Site Status

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.

San Francisco, California, United States

Site Status

Kaiser Permanente Mission Bay Medical Center Lab Drawing Station

San Francisco, California, United States

Site Status

Kaiser Permanente Medical Center Lab Drawing Station

San Jose, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

San Jose, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

San Leandro, California, United States

Site Status

UCLA Hematology/Oncology - San Luis Obispo

San Luis Obispo, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

Santa Clara, California, United States

Site Status

UCLA Hematology/Oncology - Santa Monica

Santa Monica, California, United States

Site Status

UCLA Hematology/Oncology Parkside

Santa Monica, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

South San Francisco, California, United States

Site Status

Torrance Memorial Physician Network - Cancer Care

Torrance, California, United States

Site Status

Torrance Memorial Physician Network-Cancer Care

Torrance, California, United States

Site Status

UCLA Torrance Oncology

Torrance, California, United States

Site Status

UCLA Hematology/Oncology - Santa Clarita

Valencia, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

Vallejo, California, United States

Site Status

UCLA Hematology/Oncology - Ventura

Ventura, California, United States

Site Status

Kaiser Permanente Medical Center (clinic+DSL)

Walnut Creek, California, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Aurora, Colorado, United States

Site Status

Clinical and Translational Research Center (CTRC)

Aurora, Colorado, United States

Site Status

University of Colorado Hospital - Anschutz Cancer Pavilion(ACP)

Aurora, Colorado, United States

Site Status

University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)

Aurora, Colorado, United States

Site Status

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)

Aurora, Colorado, United States

Site Status

University of Colorado Hospital

Aurora, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Boulder, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Centennial, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Colorado Springs, Colorado, United States

Site Status

UCH-MHS Memorial Hospital Central

Colorado Springs, Colorado, United States

Site Status

Printers Park Medical Plaza

Colorado Springs, Colorado, United States

Site Status

Briargate Medical Campus

Colorado Springs, Colorado, United States

Site Status

UCH-MHS Memorial Hospital North

Colorado Springs, Colorado, United States

Site Status

UCHealth Cherry Creek Medical Center

Denver, Colorado, United States

Site Status

UCHealth IDS Research Pharmacy - Cherry Creek

Denver, Colorado, United States

Site Status

Cancer Centers of Colorado at Saint Joseph Hospital

Denver, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Denver, Colorado, United States

Site Status

SCL Health Saint Joseph Hospital

Denver, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Denver, Colorado, United States

Site Status

Poudre Valley Hospital

Fort Collins, Colorado, United States

Site Status

Cancer Care & Hematology - Fort Collins

Fort Collins, Colorado, United States

Site Status

Cancer Care & Hematology - Greeley

Greeley, Colorado, United States

Site Status

SCL Health Good Samaritan Medical Center Cancer Centers of Colorado

Lafayette, Colorado, United States

Site Status

SCL Health Good Samaritan Medical Center

Lafayette, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Lakewood, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Littleton, Colorado, United States

Site Status

Rocky Mountain Cancer Centre, LLP

Lone Tree, Colorado, United States

Site Status

Cancer Care & Hematology - Loveland

Loveland, Colorado, United States

Site Status

Rocky Mountain Cancer Centers, LLP

Thornton, Colorado, United States

Site Status

Georgetown University Medical Center

Washington D.C., District of Columbia, United States

Site Status

Washington Cancer Institute at MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States

Site Status

Florida Cancer Specialists

Altamonte Springs, Florida, United States

Site Status

Florida Cancer Specialists

Bonita Springs, Florida, United States

Site Status

Florida Cancer Specialists

Brandon, Florida, United States

Site Status

Florida Cancer Specialists

Cape Coral, Florida, United States

Site Status

Florida Cancer Specialists

Clearwater, Florida, United States

Site Status

Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center

Coral Gables, Florida, United States

Site Status

Florida Cancer Specialists.

Daytona Beach, Florida, United States

Site Status

Sylvester Comprehensive Cancer Center- Deerfield Beach

Deerfield Beach, Florida, United States

Site Status

Florida Cancer Specialists - South Region

Fort Myers, Florida, United States

Site Status

Florida Cancer Specialists

Fort Myers, Florida, United States

Site Status

Florida Cancer Specialists

Fort Myers, Florida, United States

Site Status

Florida Cancer Specialists

Gainesville, Florida, United States

Site Status

Baptist MD Anderson Cancer Center

Jacksonville, Florida, United States

Site Status

Florida Cancer Specialists

Largo, Florida, United States

Site Status

Florida Cancer Specialists

Lecanto, Florida, United States

Site Status

Bascom Palmer Eye Institute

Miami, Florida, United States

Site Status

Sylvester Comprehensive Cancer Center

Miami, Florida, United States

Site Status

Miami Cancer Institute at Baptist Health, Inc.

Miami, Florida, United States

Site Status

Sylvester Comprehensive Cancer Center Kendall

Miami, Florida, United States

Site Status

Florida Cancer Specialists

Naples, Florida, United States

Site Status

Florida Cancer Specialists

Ocala, Florida, United States

Site Status

AdventHealth Orlando

Orlando, Florida, United States

Site Status

AdventHealth Hematology and Oncology

Orlando, Florida, United States

Site Status

AdventHealth Medical Group Orlando

Orlando, Florida, United States

Site Status

AdventHealth Orlando Infusion Center

Orlando, Florida, United States

Site Status

AdventHealth Orlando, Investigational Drug Services

Orlando, Florida, United States

Site Status

Florida Cancer Specialists

Orlando, Florida, United States

Site Status

Orlando Health, Inc. TRIO

Orlando, Florida, United States

Site Status

Sylvester Comprehensive Cancer Center Plantation

Plantation, Florida, United States

Site Status

Florida Cancer Specialists

Port Charlotte, Florida, United States

Site Status

Florida Cancer Specialists

Sarasota, Florida, United States

Site Status

Florida Cancer Specialists - North Region

St. Petersburg, Florida, United States

Site Status

Florida Cancer Specialists

St. Petersburg, Florida, United States

Site Status

Florida Cancer Specialists.

Stuart, Florida, United States

Site Status

Florida Cancer Specialists

Tampa, Florida, United States

Site Status

Moffitt Cancer Center, Richard M, Schulze Family Foundation Outpatient Center at McKinley Campus

Tampa, Florida, United States

Site Status

Moffitt Cancer Center

Tampa, Florida, United States

Site Status

Moffitt McKinley Hospital

Tampa, Florida, United States

Site Status

Florida Cancer Specialists

Tavares, Florida, United States

Site Status

Florida Cancer Specialists

The Villages, Florida, United States

Site Status

Florida Cancer Specialists

Trinity, Florida, United States

Site Status

Florida Cancer Specialists.

Vero Beach, Florida, United States

Site Status

Florida Cancer Specialists.

Wellington, Florida, United States

Site Status

Florida Cancer Specialists.

West Palm Beach, Florida, United States

Site Status

Northside Hospital, Inc. - GCS/ Athens

Athens, Georgia, United States

Site Status

Winship Cancer Institute, Emory University.

Atlanta, Georgia, United States

Site Status

Atlanta Cancer Care - Atlanta

Atlanta, Georgia, United States

Site Status

Northside Hospital, Inc. - Central Research Department

Atlanta, Georgia, United States

Site Status

Northside Hospital, Inc. - GCS/Northside

Atlanta, Georgia, United States

Site Status

Georgia Cancer Center at Augusta University

Augusta, Georgia, United States

Site Status

Northside Hospital, Inc. - GCS/Blairsville

Blairsville, Georgia, United States

Site Status

Northside Hospital, Inc. - GCS/Canton

Canton, Georgia, United States

Site Status

Atlanta Cancer Care - Cumming

Cumming, Georgia, United States

Site Status

Northside Hospital, Inc. - GCS/Macon

Macon, Georgia, United States

Site Status

Northside Hospital, Inc. - GCS/Kennestone

Marietta, Georgia, United States

Site Status

Hawai'i Pacific Health Research Institute - Administrative Site

Honolulu, Hawaii, United States

Site Status

Kaiser Permanente Hawaii.

Honolulu, Hawaii, United States

Site Status

Kaiser Permanente Hawaii

Honolulu, Hawaii, United States

Site Status

Kapi'olani Medical Center for Women and Children

Honolulu, Hawaii, United States

Site Status

Kapi'olani Women's Center

Honolulu, Hawaii, United States

Site Status

Illinois CancerCare- Bloomington

Bloomington, Illinois, United States

Site Status

Rush University Medical Center, Professional Office Building Infusion Pharmacy

Chicago, Illinois, United States

Site Status

Rush University Medical Center.

Chicago, Illinois, United States

Site Status

University of Chicago Medical Center, CCD- Investigational Drug Service Pharmacy

Chicago, Illinois, United States

Site Status

University of Chicago Medical Center

Chicago, Illinois, United States

Site Status

Illinois CancerCare - Galesburg

Galesburg, Illinois, United States

Site Status

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital

New Lenox, Illinois, United States

Site Status

Orland Park - University of Chicago Center for Advanced Care

Orland Park, Illinois, United States

Site Status

Illinois CancerCare- Pekin

Pekin, Illinois, United States

Site Status

Illinois CancerCare, P.C.

Peoria, Illinois, United States

Site Status

Illinois CancerCare- Peru

Peru, Illinois, United States

Site Status

Ft Wayne Medical Oncology and Hematology, Inc TRIO

Fort Wayne, Indiana, United States

Site Status

The University of Kansas Cancer Center - West

Kansas City, Kansas, United States

Site Status

MidAmerica Division, Inc. c/o Menorah Medical Center

Overland Park, Kansas, United States

Site Status

The University of Kansas Cancer Center - Overland Park

Overland Park, Kansas, United States

Site Status

The University of Kansas Cancer Center - Indian Creek Campus

Overland Park, Kansas, United States

Site Status

The University of Kansas Cancer Center Breast Surgery Center - Indian Creek Campus

Overland Park, Kansas, United States

Site Status

The University of Kansas Cancer Center, Investigational Drug Services

Westwood, Kansas, United States

Site Status

The University of Kansas Cancer Center

Westwood, Kansas, United States

Site Status

CHI Saint Joseph Cancer Care

Lexington, Kentucky, United States

Site Status

Saint Joseph Health Infusion Services

Lexington, Kentucky, United States

Site Status

University of Maryland, Greenebaum Comprehensive Cancer Center.

Baltimore, Maryland, United States

Site Status

Mercy Medical Center -Weinberg Center

Baltimore, Maryland, United States

Site Status

Mercy Medical Center.

Baltimore, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Bethesda, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Brandywine, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Columbia, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Frederick, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Largo, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Rockville, Maryland, United States

Site Status

Maryland Oncology Hematology, P.A

Silver Spring, Maryland, United States

Site Status

Brigham & Women's Hospital

Boston, Massachusetts, United States

Site Status

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Site Status

Dana Farber Cancer Institute- Chestnut Hill

Newton, Massachusetts, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Brighton Center for Specialty Care

Brighton, Michigan, United States

Site Status

Henry Ford Hospital

Detroit, Michigan, United States

Site Status

Minnesota Oncology Hematology, P.A.

Edina, Minnesota, United States

Site Status

Siteman Cancer Center - St Peters

City of Saint Peters, Missouri, United States

Site Status

Siteman Cancer Center - West County

Creve Coeur, Missouri, United States

Site Status

Siteman Cancer Center - North County

Florissant, Missouri, United States

Site Status

MidAmerica Division, Inc. c/o Centerpoint Medical Center

Independence, Missouri, United States

Site Status

Saint Luke's Cancer institute

Kansas City, Missouri, United States

Site Status

The University of Kansas Cancer Center

Kansas City, Missouri, United States

Site Status

MidAmerica Division, Inc., c/o Research Medical Center

Kansas City, Missouri, United States

Site Status

The University of Kansas Cancer Center -North

Kansas City, Missouri, United States

Site Status

The University of Kansas Cancer Center - Lee's Summit

Lee's Summit, Missouri, United States

Site Status

Barnes-Jewish Hospital

St Louis, Missouri, United States

Site Status

Washington University School of Medicine - Siteman Cancer Center.

St Louis, Missouri, United States

Site Status

Washington University School of Medicine - St. Louis

St Louis, Missouri, United States

Site Status

Siteman Cancer Center - South County

St Louis, Missouri, United States

Site Status

St. Vincent Healthcare

Billings, Montana, United States

Site Status

St. Vincent - Frontier Cancer Center

Billings, Montana, United States

Site Status

Saint Luke's Hospital Investigational Pharmacy

Ronan, Montana, United States

Site Status

Oncology Hematology West, PC dba Nebraska Cancer Specialists

Omaha, Nebraska, United States

Site Status

Oncology Hematology West, PC dba Nebraska Cancer Specialists

Omaha, Nebraska, United States

Site Status

Oncology Hematology West, PC dba Nebraska Cancer Specialists

Omaha, Nebraska, United States

Site Status

West Omaha Imaging

Omaha, Nebraska, United States

Site Status

Comprehensive Cancer Centers of Nevada

Henderson, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada

Henderson, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada Research Department

Henderson, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Summit Medical Group

Berkeley Heights, New Jersey, United States

Site Status

Summit Medical Group

Florham Park, New Jersey, United States

Site Status

Cooperman Barnabas Medical Center

Livingston, New Jersey, United States

Site Status

New York Oncology Hematology, P.C.

Albany, New York, United States

Site Status

Stony Brook Advanced Imaging

Stony Brook, New York, United States

Site Status

Stony Brook Cancer Center

Stony Brook, New York, United States

Site Status

Stony Brook University Medical Center

Stony Brook, New York, United States

Site Status

Carolinas Medical Center (biopsy only)

Charlotte, North Carolina, United States

Site Status

Charlotte Radiology Medical Center Plaza Breast Center (biopsy only)

Charlotte, North Carolina, United States

Site Status

Carolinas Medical Center Investigational Drug Services

Charlotte, North Carolina, United States

Site Status

Levine Cancer Institute

Charlotte, North Carolina, United States

Site Status

Carolinas Medical Center - Mercy (biopsy only)

Charlotte, North Carolina, United States

Site Status

Atrium Health Pineville (biopsy only)

Charlotte, North Carolina, United States

Site Status

Levine Cancer Institute-Pineville

Charlotte, North Carolina, United States

Site Status

Atrium Health University City (biopsy only)

Charlotte, North Carolina, United States

Site Status

Atrium Health Cabarrus (biopsy only)

Concord, North Carolina, United States

Site Status

Levine Cancer Institute Concord

Concord, North Carolina, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Atrium Health Union (biopsy only)

Monroe, North Carolina, United States

Site Status

OHSU Knight Cancer Institute, Beaverton

Beaverton, Oregon, United States

Site Status

Providence Cancer Institute Clackamas Clinic

Clackamas, Oregon, United States

Site Status

OHSU Knight Cancer Institute, Gresham

Gresham, Oregon, United States

Site Status

OHSU Knight Cancer Institute, Northwest Portland

Portland, Oregon, United States

Site Status

Northwest Cancer Specialists P.C.

Portland, Oregon, United States

Site Status

Providence Cancer Institute Franz Clinic

Portland, Oregon, United States

Site Status

Providence Portland Medical Center

Portland, Oregon, United States

Site Status

OHSU Knight Cancer Institute, East Portland

Portland, Oregon, United States

Site Status

Northwest Cancer Specialists P.C.

Portland, Oregon, United States

Site Status

OHSU Center for Health and Healing 2

Portland, Oregon, United States

Site Status

OHSU Center for Health and Healing

Portland, Oregon, United States

Site Status

OHSU Research Pharmacy Services

Portland, Oregon, United States

Site Status

Oregon Health And Science University

Portland, Oregon, United States

Site Status

Northwest Cancer Specialists, P.C.

Tigard, Oregon, United States

Site Status

OHSU Knight Cancer Institute, Tualatin

Tualatin, Oregon, United States

Site Status

Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine

Philadelphia, Pennsylvania, United States

Site Status

Tennessee Oncology PLLC

Dickson, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Franklin, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Gallatin, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Hendersonville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Hermitage, Tennessee, United States

Site Status

Brig Center for Cancer Care and Survivorship

Knoxville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Lebanon, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Murfreesboro, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Nashville, Tennessee, United States

Site Status

The Sarah Cannon Research Institute

Nashville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Nashville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Nashville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Nashville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Shelbyville, Tennessee, United States

Site Status

Tennessee Oncology PLLC

Smyrna, Tennessee, United States

Site Status

Texas Oncology - West Texas

Amarillo, Texas, United States

Site Status

The Center for Cancer and Blood Disorders

Arlington, Texas, United States

Site Status

Texas Oncology - Austin

Austin, Texas, United States

Site Status

Texas Oncology - Austin

Austin, Texas, United States

Site Status

Texas Oncology - DFWW

Bedford, Texas, United States

Site Status

Texas Oncology - DFW

Bedford, Texas, United States

Site Status

The Center for Cancer and Blood Disorders

Burleson, Texas, United States

Site Status

Texas Oncology - DFW

Dallas, Texas, United States

Site Status

Parkland Health and Hospital System

Dallas, Texas, United States

Site Status

Texas Oncology - DFWW

Dallas, Texas, United States

Site Status

Texas Oncology - DFW

Dallas, Texas, United States

Site Status

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center - Simmons Cancer Center Pharmacy

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center - Simmons Cancer Center

Dallas, Texas, United States

Site Status

UT Southwestern University Hospital - William P. Clements, Jr

Dallas, Texas, United States

Site Status

UT Southwestern University Hospital - Zale Lipshy

Dallas, Texas, United States

Site Status

The Center for Cancer and Blood Disorders

Fort Worth, Texas, United States

Site Status

UT Southwestern Medical Center - d/b/a Moncrief Cancer Institute - Ft. Worth - Pharmacy

Fort Worth, Texas, United States

Site Status

UT Southwestern Medical Center d/b/a Moncrief Cancer Institute - Ft. Worth

Fort Worth, Texas, United States

Site Status

Oncology Consultants, P.A.

Houston, Texas, United States

Site Status

Texas Oncology - Gulf Coast

Houston, Texas, United States

Site Status

Baylor College of Medicine Medical center

Houston, Texas, United States

Site Status

Baylor St. Luke's Medical Center

Houston, Texas, United States

Site Status

Harris Health System - Ben Taub General Hospital

Houston, Texas, United States

Site Status

Oncology Consultants, P.A.

Houston, Texas, United States

Site Status

Harris Health System - Smith Clinic

Houston, Texas, United States

Site Status

Texas Oncology - San Antonio

New Braunfels, Texas, United States

Site Status

UT Southwestern Medical Center - Clinical Center Richardson/Plano - Pharmacy

Richardson, Texas, United States

Site Status

UT Southwestern Medical Center - Clinical Center Richardson/Plano

Richardson, Texas, United States

Site Status

Texas Oncology-San Antonio

San Antonio, Texas, United States

Site Status

Texas Oncology-San Antonio

San Antonio, Texas, United States

Site Status

Texas Oncology-San Antonio

San Antonio, Texas, United States

Site Status

The Center for Cancer and Blood Disorders

Weatherford, Texas, United States

Site Status

University of Utah, Farmington Health Center

Farmington, Utah, United States

Site Status

University of Utah, Sugar House Health Center

Salt Lake City, Utah, United States

Site Status

University of Utah, Huntsman Cancer Hospital

Salt Lake City, Utah, United States

Site Status

University of Utah, Huntsman Cancer Institute

Salt Lake City, Utah, United States

Site Status

University of Utah, South Jordan Health Center

South Jordan, Utah, United States

Site Status

Virginia Cancer Specialists, PC

Alexandria, Virginia, United States

Site Status

Virginia Cancer Specialists, PC

Arlington, Virginia, United States

Site Status

Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care

Blacksburg, Virginia, United States

Site Status

Virginia Cancer Specialists, PC

Fairfax, Virginia, United States

Site Status

Virginia Cancer Specialists, PC

Gainesville, Virginia, United States

Site Status

Virginia Cancer Specialists, PC

Leesburg, Virginia, United States

Site Status

Oncology and Hematology Associates of Southwest Virginia Inc

Low Moor, Virginia, United States

Site Status

Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care

Roanoke, Virginia, United States

Site Status

Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care

Salem, Virginia, United States

Site Status

Oncology and Hematology Associates of Southwest Virginia Inc

Wytheville, Virginia, United States

Site Status

Swedish Cancer Institute - Edmonds Campus

Edmonds, Washington, United States

Site Status

Swedish Cancer Institute - Issaquah Campus

Issaquah, Washington, United States

Site Status

Swedish Cancer Institute

Seattle, Washington, United States

Site Status

Swedish Medical Center

Seattle, Washington, United States

Site Status

Northwest Cancer Specialists P.C.

Vancouver, Washington, United States

Site Status

Patricia Ritchie Centre for Cancer Care and Research Mater Hospital Sydney

North Sydney, New South Wales, Australia

Site Status

The Crown Princess Mary Cancer Centre, Westmead Hospital

Westmead, New South Wales, Australia

Site Status

Austin Health

Heidelberg, Victoria, Australia

Site Status

Peter MacCallum Cancer Centre

Melbourne, Victoria, Australia

Site Status

The Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Epic Pharmacy Hollywood

Nedlands, Western Australia, Australia

Site Status

Hollywood Private Hospital

Nedlands, Western Australia, Australia

Site Status

Starcevich Day Clinic, Hollywood Private Hospital

Nedlands, Western Australia, Australia

Site Status

Breast Cancer Research Centre - WA

Nedlands, , Australia

Site Status

Universitatsklinik Innsbruck fur Gynakologie und Geburtshilfe BrustGesundheitzentrum

Innsbruck, , Austria

Site Status

CT/MRIfacility:Diagnosezentrum Urania

Vienna, , Austria

Site Status

Klinik Ottakring.

Vienna, , Austria

Site Status

Wilhelminen Krebsforschung GmbH

Vienna, , Austria

Site Status

Institut Jules Bordet

Anderlecht, Bruxelles-capitale, Région de, Belgium

Site Status

Clinical Trails Conduct Unit(CTCU) Institut Jules Bordet

Brussels, , Belgium

Site Status

GHdC

Charleroi, , Belgium

Site Status

University Hospital Antwerp

Edegem, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

UZ Leuven

Leuven, , Belgium

Site Status

CHU de Liege

Liège, , Belgium

Site Status

CHU UCL Site Sainte Elisabeth

Namur, , Belgium

Site Status

Cross Cancer Institute

Edmonton, Alberta, Canada

Site Status

London Regional Cancer Program, London Health Sciences Centre

London, Ontario, Canada

Site Status

The Ottawa Hospital Cancer Centre

Ottawa, Ontario, Canada

Site Status

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Site Status

Centre Hospitalier de l'Universite de Motreal (CHUM)

Montreal, Quebec, Canada

Site Status

CHU de Québec-Université Laval, St-Sacrement Hospital

Québec, , Canada

Site Status

Maternal and child Health Hospital of Guangdong Province

Guangzhou, Guangdong, China

Site Status

Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, China

Site Status

Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, China

Site Status

Henan Cancer Hospital

Zhengzhou, Henan, China

Site Status

Hunan Cancer Hospital.

Changsha, Hu'nan, China

Site Status

Renmin Hospital of Wuhan University

Wuhan, Hubei, China

Site Status

Hubei Cancer Hospital

Wuhan, Hubei, China

Site Status

Nanjing Drum Tower Hospital , The Affiliated Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China

Site Status

Xuzhou Central Hospital

Xuzhou, Jiangsu, China

Site Status

Nanchang Third Hospital

Nanchang, Jiangxi, China

Site Status

Jilin Cancer Hospital

Changchun, Jilin, China

Site Status

Shengjing Hospital Of China Medical University

Shenyang, Liaoning, China

Site Status

The First Affiliated Hospital of Xi'an Jiaotong University

Xi’an, Shanxi, China

Site Status

Xi'an International Medical Center Hospital

Xi’an, Shanxi, China

Site Status

Zigong First People's Hospital

Zigong, Sichuan, China

Site Status

Tianjin Cancer Hospital

Tianjin, Tianjin Municipality, China

Site Status

The First Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

Beijing Hospital

Beijing, , China

Site Status

Cancer Hospital Chinese Academy of medical sciences

Beijing, , China

Site Status

Peking University People's Hospital

Beijing, , China

Site Status

Zhejiang Cancer Hospital

Hangzhou, , China

Site Status

Guangxi Medical University Affiliated Tumor Hospital

Nanning, , China

Site Status

Tianjin Cancer Hospital

Tianjin, , China

Site Status

Blandecentralen Odense Universitetshospital

Odense C, Other, Denmark

Site Status

Onkologisk Afdeling R, Odense Universitetshospital

Odense C, Other, Denmark

Site Status

Pharmacy.

Vejle, Other, Denmark

Site Status

Herlev og Gentofte Hospital

Herlev, , Denmark

Site Status

Pharmacy : Region Hovedstadens Apotek-KFS Serviceproduktion - Cytostatikaenheden

Herlev, , Denmark

Site Status

Radiology: Herlev - og Gentofte Hospital - Radiologisk afdeling

Herlev, , Denmark

Site Status

Radiology.

Vejle, , Denmark

Site Status

Vejle Sygehus

Vejle, , Denmark

Site Status

University Hospital of Besancon

Besançon, Other, France

Site Status

Service de Pharmacie Centre Francois Baclesse

Caen, Other, France

Site Status

Service de radiologie Centre Francois Baclesse

Caen, Other, France

Site Status

Department de Radiodiagnostic Centre GF Leclerc

Dijon, Other, France

Site Status

Service Pharmacie Centre GF Leclerc

Dijon, Other, France

Site Status

Centre Leon Berard - Centre regional de lutte contre le cancer Rhone-Alpes

Lyon, Other, France

Site Status

Departement de radiologie Hopital Bretonneau - CHRU de Tours

Tours, Other, France

Site Status

Hopital Bretonneau CHRU de Tours

Tours, Other, France

Site Status

Pharmacie Hopital Bretonneau - CHRU de Tours

Tours, Other, France

Site Status

Departement de radiologie Clinique Victor Hugo

Le Mans, Sarthe, France

Site Status

CHRU Besancon Service Radiologie

Besançon, , France

Site Status

CHRU Besancon

Besançon, , France

Site Status

Dimeo lmagerie Medicale Polyclinique - Besancon

Besançon, , France

Site Status

CHRU Morvan Pharmacie des essais cliniques

Brest, , France

Site Status

CHRU Morvan Unité de recherche clinique en cancérologie

Brest, , France

Site Status

Centre Francois Baclesse

Caen, , France

Site Status

Centre GF Leclerc

Dijon, , France

Site Status

Clinique du mail

Grenoble, , France

Site Status

Clinique Victor Hugo Centre de Cancerologie de la Sarthe

Le Mans, , France

Site Status

Centre Leon Berard Departement de Medecine

Lyon, , France

Site Status

Departement de radiologie Centre Leon Berard

Lyon, , France

Site Status

Pharmacie - Secteur essais Cliniques Centre Leon Berard

Lyon, , France

Site Status

Pharmacie des essais cliniques -lnstitut Paoli calmettes

Marseille, , France

Site Status

lnstitut Paoli Calmettes, Departement ONCOLOGIE MEDICALE

Marseille, , France

Site Status

Groupement hospitalier Portes de Provence Quartier Beausseret

Montélimar, , France

Site Status

Departement d'imagerie medicale Institut Curie - Site Paris

Paris, , France

Site Status

lnstitut Curie- Site Paris

Paris, , France

Site Status

Centre Paul Strauss - pharmacie

Strasbourg, , France

Site Status

lnstitut de cancerologie Strasbourg Europe

Strasbourg, , France

Site Status

IUCT-O

Toulouse, , France

Site Status

lnstitut Claudius Regaud - IUCT-O

Toulouse, , France

Site Status

Hopital Nord Franche-Comte Pole imagerie radiologie

Trévenans, , France

Site Status

Universitatsmedizin Mainz

Mainz, Other, Germany

Site Status

Universitaetsklinikum Schieswig-Holstein, Campus Kiel, Klinik f. Gynaekologie und Geburtshilfe

Kiel, , Germany

Site Status

InVO-lnstitut für Versorgungsforschung in der Onkologie GbR

Koblenz, , Germany

Site Status

Klinikum rechts der Isar, Klinik und Poliklinik fur Frauenheikunde

München, , Germany

Site Status

Sana Klinikum Offenbach GmbH Zentralinstitut fur Diagnostische und Interventionelle Radiologie

Offenbach/ Main, , Germany

Site Status

Oncology Institute, Meir Medical Center

Kfar Saba, , Israel

Site Status

Institute of Oncology - Davidoff Center, Rabin Medical Center, Beilinson Hospital

Petah Tikva, , Israel

Site Status

Oncology Institute, Kaplan Medical Center

Rehovot, , Israel

Site Status

A.O.U. Ospedali Riuniti di Ancona.

Torrette, Ancona, Italy

Site Status

Azienda Ospedaliero Universitaria di Bologna - IRCCS

Bologna, Emilia-Romagna, Italy

Site Status

Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi

Bologna, Emilia-Romagna, Italy

Site Status

Fondazione Policlinico Gemelli IRCCS

Rome, Lazio, Italy

Site Status

AUSL della Romagna. P.O. Ospedale degli lnfermi. U.O. di Oncologia.

Faenza, Ravenna, Italy

Site Status

AUSL della Romagna. P.O. Ospedale di Lugo Umberto I. U.O. di Oncologia.

Lugo, Ravenna, Italy

Site Status

AUSL della Romagna. P.O. Ospedale Cervesi. U.O. di Oncologia.

Cattolica, Rimini, Italy

Site Status

lstituto Europeo di Oncologia

Milan, , Italy

Site Status

AUSL della Romagna. P.O. Ospedale Santa Maria delle Croci. U.O. di Oncologia.

Ravenna, , Italy

Site Status

AUSL della Romagna P.O. Ospedale Infermi U.O. di Oncologia

Rimini, , Italy

Site Status

Nagoya Radiological Diagnosis Foundation, East Nagoya Imaging Diagnosis Center

Nagoya, Aichi-ken, Japan

Site Status

Aichi Cancer Center Hospital

Nagoya, Aichi-ken, Japan

Site Status

National Cancer Center Hospital East.

Kashiwa, Chiba, Japan

Site Status

Hiroshima City Hiroshima Citizens Hospital

Hiroshima, Chūgoku, Japan

Site Status

National Hospital Organization Shikoku Cancer Center

Matsuyama, Ehime, Japan

Site Status

National Hospital Organization Kyushu Cancer Center.

Fukuoka, Fukuoka, Japan

Site Status

National Hospital Organization Hokkaido Cancer Center.

Sapporo, Hokkaido, Japan

Site Status

Hyogo college of medicine hospital

Nishinomiya, Hyōgo, Japan

Site Status

University of Tsukuba Hospital

Tsukuba, Ibaraki, Japan

Site Status

Hakuaikai Medical Corporation Sagara Hospital

Kagoshima, Kagoshima-ken, Japan

Site Status

Hakuaikai Medical Corporation Sagara Perth Street Clinic

Kagoshima, Kagoshima-ken, Japan

Site Status

Koyasu Neurosurgical Clinic

Yokohama, Kanagawa, Japan

Site Status

Kanagawa Cancer Center

Yokohama, Kanagawa, Japan

Site Status

Morinomiya Hospital

Osaka, Osaka, Japan

Site Status

Saitama Cancer Center, Breast Oncology

Kitaadachi-gun, Saitama, Japan

Site Status

Shizuoka Cancer Center

Nagaizumi-cho, Shizuoka, Japan

Site Status

National Cancer Center Hospital

Chuo-ku, Tokyo, Japan

Site Status

Chiba Cancer Center

Chiba, , Japan

Site Status

Advanced Imaging Center

Ibaraki, , Japan

Site Status

Kumamoto Shinto General Hospital

Kumamoto, , Japan

Site Status

National Hospital Organization Osaka National Hospital

Osaka, , Japan

Site Status

Osaka Prefectural Hospital Organization Osaka International Cancer Institute

Osaka, , Japan

Site Status

The Cancer Institute Hospital of JFCR

Tokyo, , Japan

Site Status

Amphia Ziekenhuis

Breda, , Netherlands

Site Status

Martini Ziekenhuis

Groningen, , Netherlands

Site Status

Erasmus Medisch Centrum Daniel Den Hoed

Rotterdam, , Netherlands

Site Status

National Cancer Centre Singapore

Singapore, Other, Singapore

Site Status

National University Hospital

Singapore, , Singapore

Site Status

National Cancer Center

Goyang-si, Gyeonggi-do, South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Site Status

National Cancer Center

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Hospital Universitario Son Espases

Palma de Mallorca, Balearic Islands, Spain

Site Status

Hospital Quiron Barcelona

Barcelona, Other, Spain

Site Status

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, Spain

Site Status

Vall d'Hebron University Hospital

Barcelona, , Spain

Site Status

Hospital Universitario Reina Sofia

Córdoba, , Spain

Site Status

Clinica Nuestra Senora del Rosario

Madrid, , Spain

Site Status

Hospital Ruber Internacional

Madrid, , Spain

Site Status

Hospital Universitario Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario HM Sanchinarro

Madrid, , Spain

Site Status

Hospital Moises Broggi- ICO

Sant Joan Despí, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Hospital Clinico Universitario de Valencia

Valencia, , Spain

Site Status

Hospital Quirón Zaragoza

Zaragoza, , Spain

Site Status

Hospital Universitario Miguel Servet

Zaragoza, , Spain

Site Status

Sahlgrenska University Hospital

Gothenburg, , Sweden

Site Status

Onkologkliniken, KPE, Malpunkt K,

J0nkoping, , Sweden

Site Status

Centre Hospitalier Universitaire Vaudois

Lausanne, , Switzerland

Site Status

Kantonsspital Winterthur Onkologie

Winterthur, , Switzerland

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

The Royal Cornwall Hospital

Truro, Cornwall, United Kingdom

Site Status

"Edinburgh Cancer Centre, Western General Hospital,"

Edinburgh, Scotland, United Kingdom

Site Status

University Hospitals Birmingham NHS Foundation Trust Queen Elizabeth Hospital

Birmingham, , United Kingdom

Site Status

The Royal Marsden NHS Foundation Trust

London, , United Kingdom

Site Status

The Christie NHS Foundation Trust

Manchester, , United Kingdom

Site Status

The Royal Marsden NHS Foundation Trust

Sutton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada China Denmark France Germany Israel Italy Japan Netherlands Singapore South Korea Spain Sweden Switzerland Taiwan United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Hurvitz SA, Loi S, O'Shaughnessy J, Okines AFC, Tolaney SM, Sohn J, Saura C, Zhu X, Cameron D, Bachelot T, Hamilton E, Curigliano G, Wolff AC, Harbeck N, Masuda N, Vahdat L, Zaman K, Valdes-Albini F, Block M, Pluard T, Tan TJ, Gawryletz C, Chan A, Bedard PL, Yerushalmi R, Xu B, Schmitt M, Xie D, Borges VF; HER2CLIMB-02 study investigators. Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02. Ann Oncol. 2025 Nov 17:S0923-7534(25)06263-5. doi: 10.1016/j.annonc.2025.11.005. Online ahead of print.

Reference Type DERIVED
PMID: 41260264 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://pmiform.com/clinical-trial-info-request?StudyID=SGNTUC-016

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C4251001

Identifier Type: OTHER

Identifier Source: secondary_id

2024-514733-38-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

SGNTUC-016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
NCT03587740 ACTIVE_NOT_RECRUITING PHASE2
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
NCT01853748 ACTIVE_NOT_RECRUITING PHASE2